Research!America Advocacy Award Honours March Of Dimes

March of Dimes was honored March 16, 2010, at the 14th Annual Research!America Advocacy Awards event at the Andrew W. Mellon Auditorium in Washington, DC. Jennifer L. Howse, PhD, March of Dimes president, and Anna Eleanor Roosevelt, granddaughter of March of Dimes founder President Franklin Delano Roosevelt, accepted the award…

Women Who Witness Sexism May View All Men More Negatively

For every woman who is a direct target of sexism, there are others who witness the event and are also affected. The actions of one sexist man affect how female bystanders feel and behave towards men in general…

Survey Results Raise Concerns About Women’s Perceptions On Risks Associated With Elective Deliveries

Results of a national survey point to a greater need to educate women on the risks associated with early elective cesarean sections and labor inductions. A recent survey by UnitedHealthcare of first-time mothers found more than half the respondents believe it is safe to deliver their baby before 37 weeks’ gestation even if not [...]

Arizona Cancels SCHIP Program for Lack of Funds

Arizona has become the first state to cancel its State Children’s Health Insurance Program, which, like other SCHIP programs, is funded jointly by the state and the federal government.

SGO: HPV Vaccine Stops Recurrence After Surgery (CME/CE)

SAN FRANCISCO (MedPage Today) — Vaccination against human papillomavirus (HPV) significantly reduced the risk of recurrence after surgery for HPV-related cervical lesions, according to data reported here.

More Lots of BP Drug Recalled

The manufacturer of the injectable calcium channel blocker clevidipine (Cleviprex) voluntarily recalled an additional four lots of the drug because of debris floating in the suspension.

FDA Clears Non-Abusable Insomnia Treatment

WASHINGTON (MedPage Today) — The FDA approved doxepin (Silenor) for use in patients with long or short term insomnia and sleep maintenance difficulty.

Major study shoots for personalized breast cancer drugs

Mutations in BCRA1 and BCRA2 genes are mainly associated with increased risk of breast cancer in women. Recently many other genetic variants have been found to be associated with breast cancer.

CPEX Pharmaceuticals’ Phase 2a Nasulin trial fails, Arcadia Capital Advisors issues statement

Richard S. Rofe, who serves as Managing Director for Arcadia Capital Advisors, LLC, and is part of a shareholder group that includes Arcadia with a 9.97 percent ownership interest in CPEX Pharmaceuticals, Inc.,, commented on CPEX’s recent announcement of failed Phase 2a Nasulin study results.

Synergy Pharmaceuticals commences dosing in Phase IIa clinical trial of SP-304 in CC patients

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today the initiation of dosing in a Phase IIa clinical trial of SP-304 in patients with chronic constipation (CC). This is a Phase IIa, randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-escalation study in patients with chronic constipation.